Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experience
Lionel Adès(Délégation Paris 7), Pierre Fenaux(Saint Louis University Hospital), Blandine Bève(Université Sorbonne Paris Nord), Miguel Á. Sanz(Instituto de Investigación Sanitaria La Fe), Stéphane de Botton(Université Paris-Saclay), C Garo(Université Sorbonne Paris Nord), Christine Chomienne(Inserm), Jesús F. San Miguel(Clinica Universidad de Navarra), Jean‐Yves Cahn, Sylvie Chevret(Saint Louis University Hospital), Oumédaly Reman(University of Bern), Anne Parry(Leukemia Research Foundation), Xavier Thomas(Hôpital Lyon Sud), A. Stamatoulas(University of Bern), Jessica Serna, Martin F. Fey(European Union), L Degos(Centre Hospitalier Universitaire de Lille), Anne Marie Stoppa, J. H. Bourhis(Leukemia Research Foundation), J.J. Sotto(Leukemia Research Foundation), Hervé Dombret(University of London Institute in Paris), A. Guerci(University of Bern)
Cited by 63
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k